Grenke, ich denke auch,dass wir mit Advectus bis zum Jahresende noch eine ganze Menge Spaß haben werden! In Kanada scheint sich wirklich ein solider Boden auszubilden, von dem wir sehr bald nach oben abprallen dürften! Wäre ja schön, wenn aus D klare Kaufsignale über den großen Teich zu den hysterischen Kanadiern rüberschwappen würden!!:-)
IMO werden wir dieses Jahr nochmals die alten Höchststände von 0,1€ sehen! Und sollte dann eine Meldung bzgl. der Fortschritte von Nanocube kommen, könnte die 1 auch irgendwann mal vor dem Komma stehen! Und dann gibt es 'ne Paaarty!
Prof. Kreuter ist ein absolut hohes Tier an der Goethe-Universität an der Uni Frankfurt. Ich denke, dass dies auf ein gewisses Know-How hindeutet!
Scientific Advisory Board:
Dr. Michael Morgan has over 20 years experience in the management and technical aspects of regulatory toxicology, together with extensive experience in the conduct and reporting of non-clinical toxicology studies for registration of products with the FDA and European regulatory authorities. Dr. Morgan has designed and implemented pre-clinical development plans for a major pharmaceutical company and several biotechnology companies. He has written expert reports for international dossiers supporting European submissions of major pharmaceutical and biotechnology companies, has placed and monitored several toxicology, pharmacology and pharmacokinetic studies and audited many such studies in major contract laboratories in the United States, Canada, Scotland, England and France. Dr. Morgan is an officer and a director of the Company. More...
Dr. Ed Stephen has more than 30 years experience in all aspects of biopharmaceutical research and development, as well as drug and device development. He gained postdoctoral training in pharmacology and toxicology at the University of Alabama Medical School where he lectured in pharmacology. Following his postdoctoral training, he directed the evolution of the anti-viral drug development effort for the U.S. Department of Defense. Subsequent to leaving the U.S. Army, Dr. Stephen directed the preclinical toxicology studies for the National Cancer Institute.
Dr. Stephen is currently President of Development Technologies International Inc., of Frederick, Maryland, and Senior Project Manager of ISTC (International Science and Technology Centre), Moscow, Russia. More...
Professor Jörg Kreuter received his Ph.D. in Pharmacology from the Swiss Federal Institute of Technology, Zurich and has researched and taught both in Europe and the United States for over 25 years. Currently Prof. Kreuter is Dean of the Faculty of Biochemistry, Pharmacy and Food Science at the Johann Wolfgang Goethe-University in Frankfurt, Germany. More...
For more information on Dr. Kreuter's work, visit his website at:
Dr. Svetlana Gelperina received her Ph.D. from the Russian Academy of Science, Moscow, Russian Federation. For the past 20 years Dr. Gelperina has researched both in Russia and Germany primarily in the field of polymers and their use as a drug delivery system. Currently she is the leading research associate, Moscow Research Institute of Medical Ecology. More...
da ich schon seit 0,027€ drin bin. Habe übrigens sowohl Prof. Kreuter als auch Greg Kraft (IR-Mann in Kanada) angemailt und nach aktuellen Entwicklungen gefragt. Bin mal gespannt....!
Thread abonnieren
